Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Dig Liver Dis ; 56(3): 514-521, 2024 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-37718226

RESUMEN

BACKGROUND: We sought to describe the reasons for intensive care unit (ICU) admission and outcomes of patients with pancreatic cancer requiring unplanned medical ICU admission. PATIENTS AND METHODS: Retrospective cohort study in five ICUs from 2009 to 2020. All patients with pancreatic cancer admitted to the ICU were included. Patients having undergone recent surgery were excluded (< 4 weeks). RESULTS: 269 patients were included. Tumors were mainly adenocarcinoma (90%). Main reason for admission was sepsis/septic shock (32%) with a biliary tract infection in 44 (51%) patients. Second reason for admission was gastrointestinal bleeding (28%). ICU and 3-month mortality rates were 26% and 59% respectively. Performance status 3-4 (odds ratio OR 3.58), disease status (responsive/stable -ref-, newly diagnosed OR 3.25, progressive OR 5.99), mechanical ventilation (OR 8.03), vasopressors (OR 4.19), SAPS 2 (OR 1.69) and pH (OR 0.02) were independently associated with ICU mortality. Performance status 3-4 (Hazard ratio HR 1.96) and disease status (responsive/stable -ref-, newly diagnosed HR 2.67, progressive HR 4.14) were associated with 3-month mortality. CONCLUSION: Reasons for ICU admissions of pancreatic cancer patients differ from those observed in other solid cancer. Short- and medium-term mortality are strongly influenced by performance status and disease status at ICU admission.


Asunto(s)
Neoplasias Pancreáticas , Choque Séptico , Humanos , Estudios Retrospectivos , Mortalidad Hospitalaria , Unidades de Cuidados Intensivos , Hospitalización , Neoplasias Pancreáticas/terapia
2.
Rev Med Interne ; 41(6): 375-389, 2020 Jun.
Artículo en Francés | MEDLINE | ID: mdl-32507520

RESUMEN

SARS-CoV-2 infection, named COVID-19, can lead to a dysregulated immune response and abnormal coagulation responsible for a viral sepsis. In this review, we specify physiopathological mechanisms of each phase of COVID-19 - viral, immune and pro-thrombotic - notably because they involve different treatment. Finally, we specify the physiopathological mechanisms of organ injury.


Asunto(s)
Betacoronavirus , Infecciones por Coronavirus , Pandemias , Neumonía Viral , Animales , Betacoronavirus/genética , Betacoronavirus/inmunología , Betacoronavirus/ultraestructura , COVID-19 , Infecciones por Coronavirus/complicaciones , Infecciones por Coronavirus/epidemiología , Infecciones por Coronavirus/inmunología , Infecciones por Coronavirus/terapia , Citocinas/metabolismo , Humanos , Inmunización , Inmunomodulación , Especificidad de Órganos , Neumonía Viral/complicaciones , Neumonía Viral/epidemiología , Neumonía Viral/inmunología , Neumonía Viral/terapia , SARS-CoV-2 , Trombosis/prevención & control , Trombosis/virología , Tropismo Viral , Internalización del Virus , Replicación Viral/fisiología , Zoonosis/virología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA